Morningside Venture Investments Ltd, 10% Owner at Amylyx Pharmaceuticals, Inc. (AMLX), sold 160,964 shares at $30.25 ($4.9M) on 2023-03-27, disclosed to the SEC on 2023-03-29.
Open-market sale of $4.9M AMLX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.25 | 32,964 | $997K | 20.4% |
| 2 | $30.80 | 28,000 | $862K | 17.6% |
| 3 | $30.37 | 100,000 | $3.0M | 62.0% |
| Total | $30.42 avg | 160,964 | $4.9M | 100% |
| Filing → |
| AMLX | SELL | 2023-03-23 | $4.0M | — | Filing → |
| AMLX | SELL | 2023-03-17 | $594K | — | Filing → |
| AMLX | SELL | 2023-03-16 | $14.9M | — | Filing → |